Takeda Pharmaceutical (TYO:4502) has been on a partnership spree lately, inking at least 65 collaborations and deal in the last 18 months.
Fueling those agreements is a fundamental belief that to reinvigorate the pharmaceutical industry, access to innovative science is crucial, according to Daniel Curran, SVP & head of the Japan-based company’s Center for External Innovation.
Get the full story at our sister site, Drug Delivery Business News.